The Tepezza hearing loss lawsuit is getting more public attention because additional patients are reporting hearing loss after they received Tepezza treatment for thyroid eye disease. Tepezza is an infusion medication that Horizon Therapeutics developed as a prescription drug before Amgen purchased the rights to it.  Multiple legal cases assert that the medication can lead to severe or enduring auditory harm while the manufacturers failed to provide adequate danger notificati